News

Purchase of Pieffe Group, combined with new facility launches, brings UPS capacity nearly to 5 million sq.ft. worldwide; more expected in 2012

Analysis combines financial and operational performance, and industry reputation, among manufacturers, distributors and healthcare systems

Latest study validates an observational database as a measure across disparate geographies

Specialty drug market success requires patient-focused and therapy-specific channel and services strategies

E-commerce hub is soliciting more pharma participants to evaluate data-exchange protocols

PCMA study estimates additional $32 billion in added healthcare costs through 2021; coupons ‘lure consumers to switch from generics to expensive brands’

Supplier of active and passive containers lines up regional providers in Asia, Middle East and South America

Production volumes are actually up for some short-supply drugs, indicating a disconnect between manufacturers and the marketplace. Meanwhile, NCPD fights ‘price gouging’ claim

A combination of regulatory processes and business practices are worsening an already-bad drug shortage situation

Unifying a company’s approach to marketing fulfillment activities could provide innovation while delivering cost savings

Pharma marketers become adept at refining coupon and voucher programs, while technology options multiply. Meanwhile payer criticism mounts

Long used in clinical research, cloud computing is now entering commercial and business applications

New HDMA 2011-2012 HDMA Factbook finds gradual growth in IT-based collaborations

Specialty distributors, specialty pharmacies and healthcare providers are all competing for a dominant position in drug delivery and reimbursement

Accountable care organizations will seek ‘economic and clinical value’ for pharmaceuticals

Plan to address worsening drug-shortage sitaution has note spurred legislative activity

Congressmen send a letter to TSA seeking an explanation for the delay

ComScore analysis finds CDC.gov highest-ranking site

Tracking at the lot- rather than the item-level could address many security and tracking goals

Online medical-diagnostics catalogues will have links to live pharma rep interations

Company points finger at its specialty pharmacy for unreported deaths, but still gets hit with a Form 483

New edition of HDMA Factbook sees growth in generics, and the beginning of a slide in branded-drug revenues

55% of drug-shortage causes are “unknown;” Congressional committee questions pricing, access and sources of short-supply drugs

A higher focus on market access strategies, managed markets and salesforce realignments are the elements of addressing that pain

Report focuses on the need for targeted clinical design, and commercialization strategies tailored to individual national markets